AI assistant
Roivant Sciences Ltd. — Director's Dealing 2024
Jul 31, 2024
30587_dirs_2024-07-30_900b07d0-a0ce-4459-a3a0-c637894f4044.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2024-07-26
Reporting Person: Venker Eric (President & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-26 | Common Shares | A | 204000 | — | Acquired | 650307 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-07-26 | Stock Option (Right to Buy) | $10.80 | A | 409000 | Acquired | 2034-07-25 | Common Shares (409000) | Direct |
Footnotes
F1: Reflects an award of restricted stock units with respect to Common Shares, with a vesting commencement date of April 20, 2024, which service-vest (i) 25% on May 20, 2025 and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date.
F2: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.